Safety and Efficacy of Lorlatinib (PF-06463922) in Patients with Advanced ALK+ or ROS1+Non-Small-Cell Lung Cancer (NSCLC)
JOURNAL OF THORACIC ONCOLOGY(2017)
关键词
ALK,ros1,non-small cell lung cancer,lorlatinib
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要